Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | Down syndrome cell adhesion molecule | 0.0017 | 0.0769 | 0.0769 |
Schistosoma mansoni | receptor tyrosine phosphatase type r2a | 0.0017 | 0.0769 | 0.0769 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0029 | 0.3645 | 0.3116 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.002 | 0.1318 | 0.1318 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.002 | 0.1318 | 0.1318 |
Schistosoma mansoni | cell adhesion molecule | 0.0017 | 0.0769 | 0.0769 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0026 | 0.2866 | 0.2866 |
Brugia malayi | hypothetical protein | 0.003 | 0.3969 | 0.3467 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.3969 | 0.3467 |
Echinococcus granulosus | Down syndrome cell adhesion molecule | 0.0017 | 0.0769 | 0.0769 |
Echinococcus multilocularis | roundabout 2 | 0.0017 | 0.0769 | 0.0769 |
Echinococcus multilocularis | neuroglian | 0.0017 | 0.0769 | 0.0769 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.0017 | 0.0769 | 0.0769 |
Echinococcus multilocularis | Immunoglobulin | 0.002 | 0.1318 | 0.1318 |
Schistosoma mansoni | nephrin | 0.003 | 0.3969 | 0.3969 |
Echinococcus granulosus | neuroglian | 0.0017 | 0.0769 | 0.0769 |
Echinococcus granulosus | neuroglian | 0.002 | 0.1318 | 0.1318 |
Echinococcus multilocularis | neuroglian | 0.002 | 0.1318 | 0.1318 |
Echinococcus granulosus | roundabout 2 | 0.0037 | 0.5517 | 0.5517 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase | 0.0017 | 0.0769 | 0.0769 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.003 | 0.3969 | 0.3467 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.2866 | 0.2272 |
Echinococcus multilocularis | receptor type tyrosine protein phosphatase F | 0.0017 | 0.0769 | 0.0769 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.002 | 0.1318 | 0.1318 |
Echinococcus multilocularis | contactin neuroglian septate junction protein | 0.0017 | 0.0769 | 0.0769 |
Schistosoma mansoni | neuroglian | 0.0017 | 0.0769 | 0.0769 |
Echinococcus multilocularis | roundabout 2 | 0.0037 | 0.5517 | 0.5517 |
Schistosoma mansoni | vesicular amine transporter | 0.002 | 0.1318 | 0.1318 |
Echinococcus granulosus | roundabout 2 | 0.0017 | 0.0769 | 0.0769 |
Echinococcus granulosus | roundabout 2 | 0.0017 | 0.0769 | 0.0769 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.1318 | 0.0595 |
Echinococcus granulosus | contactin | 0.0017 | 0.0769 | 0.0769 |
Echinococcus multilocularis | roundabout 2 | 0.0017 | 0.0769 | 0.0769 |
Echinococcus granulosus | Immunoglobulin | 0.002 | 0.1318 | 0.1318 |
Brugia malayi | Fibronectin type III domain containing protein | 0.003 | 0.3969 | 0.3467 |
Schistosoma mansoni | nephrin | 0.0017 | 0.0769 | 0.0769 |
Schistosoma mansoni | cell adhesion molecule | 0.0017 | 0.0769 | 0.0769 |
Echinococcus granulosus | receptor type tyrosine protein phosphatase | 0.0017 | 0.0769 | 0.0769 |
Echinococcus granulosus | defective proboscis extension response | 0.002 | 0.1318 | 0.1318 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.3969 | 0.3467 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.1318 | 0.0595 |
Echinococcus multilocularis | Immunoglobulin | 0.002 | 0.1318 | 0.1318 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.2866 | 0.2272 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0029 | 0.3645 | 0.3116 |
Schistosoma mansoni | cell adhesion molecule | 0.0037 | 0.5517 | 0.5517 |
Echinococcus granulosus | twitchin | 0.002 | 0.1318 | 0.1318 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.2866 | 0.2272 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.1318 | 0.0595 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.3969 | 0.3467 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.6234 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.